HealthcareServices

Osteoarthritis Market Outlook 2025 – Insights for Executive and Strategic Planning

July 2, 2025 by Marketing Posting

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

#How Has the Osteoarthritis Market Grown from 2024 to 2025?#_x000D_

In the past few years, the market for osteoarthritis has seen robust growth. It is expected to expand from $6.87 billion in 2024 to $7.53 billion in 2025, marking a compound annual growth rate (CAGR) of 9.6%. Several factors have contributed to this growth during the historic period, including an aging population, the obesity crisis, and advancements in imaging and pain management._x000D_

_x000D_

#What Growth Rate Is Anticipated for the Osteoarthritis Market in the Coming Years?#_x000D_

In the coming years, the osteoarthritis market is projected to experience significant growth, rising to a value of $10.64 billion in 2029, with a compound annual growth rate (CAGR) of 9.0%. Non-pharmacological methods, disease-altering osteoarthritis drugs (dmoads), personalized treatments, telehealth, and distant tracking can all contribute to this growth throughout the projected period. Regenerative treatments, wearable technology, the use of artificial intelligence for diagnosis, and digital health resources are among the key trends predicted for this period._x000D_

_x000D_

#Download The Free Sample Report Here:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=13022&type=smp_x000D_

_x000D_

#Who Are the Leading Companies in the Osteoarthritis Market?#_x000D_

Major companies operating in the osteoarthritis market are Pfizer Inc., Johnson & Johnson, Merck Sharp & Dohme Corp., Abbvie Inc., Bayer AG, Novartis AG, Sanofi SA, AstraZeneca PLC, Abbott Laboratories Incorporation, Eli Lilly and Company, Boehringer Ingelheim, Novo Nordisk A/S, Reckitt Benckiser Group PLC, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Mylan N.V., Astellas Pharma Inc., Zimmer Biomet Holdings Inc., Eisai Co. Ltd., Horizon Therapeutics PLC, Apotex Inc., Mallinckrodt Pharmaceuticals, Pacira BioSciences Inc., Bioventus Inc., Endo Pharmaceuticals Inc., Assertio Therapeutics Inc., Anika Therapeutics Inc., Abiogen Pharma Spa, Kolon TissueGene Inc., Ampio Pharmaceuticals Inc._x000D_

_x000D_

#What Are the Key Drivers of the Osteoarthritis Market?#_x000D_

The growth of the osteoarthritis market is predicted to be fuelled by the rise in obesity-related disorders. These health issues stem from carrying excess body fat, which can be the result of consuming more calories than the body uses, the intake of high volumes of processed food, and excessive alcohol consumption. Obesity increases the chance of osteoarthritis as it places additional pressure on the joints, triggers inflammation, and interferes with hormone regulation, thereby adding more load on the joints. For example, the World Obesity Atlas 2022, presented by the UK-based World Obesity Federation, states that by 2030, obesity will affect 1 billion individuals across the globe, including 1 out of every 7 men and 1 in every 5 women. It is also projected that by 2035, this will escalate to 4 billion people, representing 51% of the global population, who will be overweight or obese. Thus, the growing prevalence of obesity-related disorders is contributing to the expansion of the osteoarthritis market.

Driver for Osteoarthritis Market Growth: Boost from Extensive Use of Painkillers

_x000D_

#Request For A Customized Report:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=13022&type=smp_x000D_

_x000D_

#What Are the Key Market Segments in the Osteoarthritis Industry?#_x000D_

The osteoarthritis market covered in this report is segmented –_x000D_

_x000D_

1) By Treatment: Medication, Surgery, Therapy_x000D_

2) By Diagnosis: Imaging, Joint Fluid Analysis_x000D_

3) By Route Of Administration: Parenteral Route, Topical Route, Oral Route_x000D_

4) By Disease Type: Knee Osteoarthritis, Spine Osteoarthritis, Foot And Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis_x000D_

5) By End-User: Hospitals, Medical Institutes_x000D_

_x000D_

Subsegments:_x000D_

1) By Medication: Pain Relievers, Corticosteroids, Hyaluronic Acid Injections, Disease-Modifying Osteoarthritis Drugs (DMOADs)_x000D_

2) By Surgery: Joint Replacement Surgery, Arthroscopy, Osteotomy, Joint Fusion_x000D_

3) By Therapy: Physical Therapy, Occupational Therapy, Weight Management Programs, Assistive Devices_x000D_

_x000D_

#What Are the Latest Trends in the Osteoarthritis Market?#_x000D_

Leading firms in the osteoarthritis sector are employing strategic alliances as a means to improve technology fusion and broaden their market influence. Strategic partnership is often used to describe a cooperative interaction between two or more firms, where they merge their resources, knowledge, and energy to attain mutual targets or aims. For example, in July 2024, South Korea’s LG Chem moved into the Chinese market through a collaboration with Yifan Pharmaceutical Co., Ltd., a China-based pharmaceutical research and manufacture firm. This partnership allowed them to introduce Synovian injection for osteoarthritis which carries similar therapeutic capacities as conventional multi-injection formulations, but requires only a single dose. Synovian’s distinctive attributes include its high molecular weight (10 million Dalton) hyaluronic acid, which improves viscoelasticity and joint functionality, and its proven ability to significantly alleviate knee pain based on phase 3 clinical trial outcomes. These developments position Synovian as a viable choice for patients seeking easy relief from osteoarthritis symptoms._x000D_

_x000D_

#Access The Full Report Here:#_x000D_

https://www.thebusinessresearchcompany.com/report/osteoarthritis-global-market-report_x000D_

_x000D_

#What Are the Key Regional Markets in the Osteoarthritis Industry?#_x000D_

North America was the largest region in the osteoarthritis market in 2024. The regions covered in osteoarthritis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa._x000D_

_x000D_

#Purchase The Full Report Today:#_x000D_

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13022_x000D_

_x000D_

#This Report Delivers Insight On: #_x000D_

1. How big is the osteoarthritis market, and how is it changing globally?_x000D_

2. Who are the major companies in the osteoarthritis market, and how are they performing?_x000D_

3. What are the key opportunities and risks in the osteoarthritis market right now?_x000D_

4. Which products or customer segments are growing the most in the osteoarthritis market?_x000D_

5. What factors are helping or slowing down the growth of the osteoarthritis market?_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Asia +44 2071930708_x000D_

Europe +44 7882 955267_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_